Stocks and Investing Stocks and Investing
Mon, August 7, 2023

Eric Joseph Maintained (TGTX) at Buy with Decreased Target to $22 on, Aug 7th, 2023


Published on 2024-10-28 05:36:51 - WOPRAI, Eric Joseph
  Print publication without navigation


Eric Joseph of JP Morgan, Maintained "TG Therapeutics, Inc." (TGTX) at Buy with Decreased Target from $34 to $22 on, Aug 7th, 2023.

Eric has made no other calls on TGTX in the last 4 months.



There are 5 other peers that have a rating on TGTX. Out of the 5 peers that are also analyzing TGTX, 1 agrees with Eric's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Corinne Jenkins of "Goldman Sachs" Maintained at Hold with Decreased Target to $12 on, Thursday, August 3rd, 2023


These are the ratings of the 4 analyists that currently disagree with Eric


  • Mayank Mamtani of "B. Riley Securities" Maintained at Strong Buy with Decreased Target to $32 on, Wednesday, August 2nd, 2023
  • Edward White of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $41 on, Tuesday, August 1st, 2023
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, May 2nd, 2023
  • Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023
Contributing Sources